News | November 25, 2021
Sputnik Light in India by December: RDIF
One-shot Sputnik Light is a highly effective vaccine when used both on standalone basis and applied as a booster
One-shot Sputnik Light is a highly effective vaccine when used both on standalone basis and applied as a booster
Launching in 2022, its availability will be expanded to the global market
This test is inexpensive and results are available immediately as compared to the genetic test
The ground-breaking project, led by Genomics England and NHS England, was established in 2013 to sequence 100,000 whole genomes from NHS patients and their families
Thermo Fisher Scientific expands diagnostics portfolio to support full qPCR assay development and testing workflow
Sputnik Light has been authorised in more than 15 countries with the registration process ongoing in a further 30 countries
It is the first integrated digital PCR solution ideal for oncology, cell and gene therapy development
The applications navigate through more than 100 workflows across biotech, pharma, healthcare, food, forensics, industrial and applied sciences industries
Next-generation radiofrequency catheter offers first thermal ablation perforator treatment advancement in over 10 years
Takeda to exclusively commercialize JR-141 outside the U.S. (except Japan and certain other Asia-Pacific countries) upon regulatory approval
Subscribe To Our Newsletter & Stay Updated
